Maria C.
- Country
- Poland
- Department
- Klinika Hematoonkologii i Transplantacj
Research Overview
- Efficacy and Safety Evaluation of Luspatercept in Lower-Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
- A Phase 3, Open -label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions.
Data & Insights
Has run more than one trial at 14 of 73 partner sites.
Specializations
Hematological Disorders
This investigator specializes in treating myelodysplastic syndrome (MDS), with particular focus on managing patients with very low to intermediate risk classifications according to the International Prognostic Scoring System-Revised (IPSS-R).
- Lower-risk MDS management
- Transfusion-dependent anemia
- Novel therapeutic approaches
Their research encompasses innovative treatments for anemia associated with MDS, particularly in patients requiring regular red blood cell transfusions.
Anemia Management
The investigator focuses on developing treatment strategies for transfusion-dependent anemia, particularly exploring novel therapeutic agents for improving hemoglobin levels and reducing transfusion dependency.
- Red blood cell transfusion independence
- Hemoglobin level optimization
- ESA-naïve patient treatment
Their work includes evaluating comparative efficacy of different treatment approaches in managing anemia in MDS patients.
Therapeutic Innovation
The investigator specializes in evaluating novel therapeutic agents for hematological conditions, with emphasis on treatments that could reduce transfusion dependency in MDS patients.
- Advanced treatment protocols
- Patient response assessment
- Long-term outcome evaluation
Their research interests include investigating treatments for patients who have not previously received certain therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.